All good Steady T unless it gives Biogunk a leg up on hostile actions towards acquiring us. They ARE familiar with our MOA as they were allowed to study our drug and they have all kinds of threatening patent issues with their MS portfolio. Does Dr. Missling and the BOD have a plan in place sufficient enough to thwart this event? Desparate times sometimes call for desperate measures by competitors.